- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/265 - Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
Patent holdings for IPC class A61K 31/265
Total number of patents in this class: 228
10-year publication summary
|
11
|
14
|
17
|
12
|
26
|
18
|
15
|
13
|
13
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Rockefeller University | 579 |
8 |
| The Johns Hopkins University | 5796 |
7 |
| Advanced Biodesign | 19 |
6 |
| Colgate-Palmolive Company | 5740 |
5 |
| Martin Pharmaceuticals Inc | 9 |
5 |
| F. Hoffmann-La Roche AG | 7832 |
4 |
| Promentis Pharmaceuticals, Inc. | 15 |
4 |
| XenoPort, Inc. | 81 |
4 |
| Zynerba Pharmaceuticals, Inc. | 45 |
4 |
| Bioprojet | 44 |
3 |
| Children's Hospital Medical Center | 735 |
3 |
| The Cooper Health System | 43 |
3 |
| Mitochon Pharmaceuticals, Inc. | 15 |
3 |
| SRI International | 995 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 859 |
3 |
| United Therapeutics Corporation | 325 |
3 |
| Johnson & Johnson Consumer Inc. | 337 |
3 |
| Bioventures, LLC | 230 |
3 |
| Theravance Biopharma R&D IP, LLC | 428 |
3 |
| Galleon Labs LLC | 12 |
3 |
| Other owners | 148 |